
Common Infections in Aged Care
By Lyndon Forrest, Managing Director · Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors · September 2026
Candida auris: Screening and Precautions for Aged Care
TL;DR —
Candida auris is a multi-drug-resistant yeast that can spread in care settings and persist on skin and surfaces. In Australia, it is monitored through CARAlert and is notifiable in some states and territories. This guide explains who is at risk, when to screen, and the precautions that apply, with clinical specifics flagged for local confirmation.

Key takeaways
Candida auris (C. auris) is a yeast that is resistant to several antifungal medicines and can cause serious infection in residents (ACSQHC, 2025).
The most common risk factor in Australia is recent healthcare in an overseas facility of any type, including hospitals and residential care, in the past 12 months (Queensland Health, 2024).
C. auris persists on skin and surfaces, so screening, precautions, and thorough environmental cleaning are central to control.
A resident with a history of C. auris is generally considered potentially infectious indefinitely, and contact precautions apply on each admission (Victoria Health, NSW CEC, 2025).
Most national and state guidance is written for hospitals; confirm the aged care application with your state or territory public health unit.
Need help implementing this in your facility? The IPS Hub gives your IPC Lead instant access to ready-made policies, procedures, and audit tools — updated monthly.
What is Candida auris and why does it matter in aged care?
Candida auris is a fungus (yeast) resistant to a range of antifungal medicines, and it can cause serious infections in people who are immunocompromised. Correct identification and management matter for both treatment and control (ACSQHC, 2025).
It spreads through contact with colonised or infected people and with contaminated surfaces and equipment, and it can persist in the environment. The World Health Organisation lists it as a priority fungal pathogen (WHO, 2022). These features mean C. auris is managed more like a multi-resistant organism than common Candida or thrush.
How common is Candida auris in Australia and New Zealand?
In Australia, C. auris is monitored through the National Alert System for Critical Antimicrobial Resistance (CARAlert), and it is notifiable in some states and territories. Reports remain relatively low, and CARAlert data show that the number of isolates has been rising over the past five years (ACSQHC, 2025).
New Zealand monitors antimicrobial-resistant organisms through its own national systems. Facilities should confirm the current C. auris notification position and guidance with the relevant New Zealand authority. Te Whatu Ora published IPC guidance on C auris for healthcare workers on 5 April 2023.
Who is at risk of Candida auris in residential aged care?
The most common risk factor in Australia is recent admission to an overseas healthcare facility of any type – including hospitals and residential care – in the past 12 months (Queensland Health, 2024; ACSQHC, 2025). ICU admission carries particular risk, but the broader trigger for assessment is any overseas inpatient healthcare contact within this period. Other recognised risks include indwelling devices such as urinary catheters, recent use of broad-spectrum antibiotics or antifungal use, and immunocompromised status. A resident transferred from a hospital with a known C. auris case may warrant assessment.
When should a facility screen for Candida auris?
Screening is targeted, not routine. It generally applies to people with a history of C. auris and to close contacts of a known case, to detect whether spread has occurred (NSW CEC, 2025; ACSQHC, 2025).
In residential aged care, the decision to screen a resident – for example, on admission from a hospital with a C. auris case – should be made with the resident’s general practitioner and the state or territory public health unit. Screening is by a composite swab of both axillae and groin (ASID, 2019; Queensland Health, 2024). Your laboratory or public health unit will advise on collection and any additional sites.
What precautions apply to a resident with Candida auris?
For a resident with C. auris colonisation or infection, recognised measures include single room care with an ensuite, contact precautions, strict hand hygiene on entering and leaving the room, and dedicated equipment. Single-use items are encouraged, and shared equipment is cleaned and disinfected before reuse (NSW CEC, 2025; Queensland Health, 2024). Residents can usually continue communal activities and leave their room provided that wounds are covered, secretions and body fluids are contained, and they can perform hand hygiene before leaving. Precautions are adapted to the aged care setting and are not simply transplanted from the hospital (Queensland Health, 2024). Confirm the approach with your state or territory public health unit.
A person with a history of C. auris is generally considered potentially infectious indefinitely, and contact precautions apply each time they enter a facility until discharge (NSW CEC, 2025). Applying these measures in a home-like setting needs a balance with resident dignity – see the Residents, Families and Community pillar.
How should facilities clean the environment and equipment?
C. auris survives on surfaces, so routine and discharge cleaning both matter. Clean with detergent, then use a TGA-listed hospital-grade disinfectant with demonstrated activity against Candida auris (check the product’s label claim or manufacturer’s validation data), or a combined detergent and disinfectant wipe with the same claim. Chlorine-based and hydrogen peroxide-based products have shown activity; some quaternary ammonium compound products are unreliable against C. auris, so do not assume a standard product is effective. Follow the manufacturer’s contact time and dilution, and thoroughly clean frequently touched surfaces and shared equipment.
Reusable equipment should be reprocessed according to the manufacturer’s and state guidance. The Environmental Cleaning and Waste Management pillar covers cleaning methods and product selection in detail.
Is Candida auris notifiable, and when is a resident considered clear?
C. auris is notifiable in some Australian states, including Victoria, South Australia, New South Wales and Western Australia. In Queensland it is not currently a statutory notifiable condition, but confirmed cases should still be reported to Queensland Health. Notification requirements and timeframes differ, so confirm them with your state or territory health department before a case arises.
“Clearance” — deciding that a person no longer carries C. auris — follows specific criteria and repeat testing, and it is a clinical and public health decision rather than a facility one (ACSQHC, 2025). NB; decolonisation isn’t reliably achievable, and most guidance treats prior cases as indefinitely potentially colonised.
Related articles in the knowledge base
Appropriate Antibiotic Prescribing
UTI or Asymptomatic Bacteriuria
Building Infection Prevention into Clinical Governance
AMS Compliance Under the New Aged Care Quality Standards.
Frequently Asked Questions
Is Candida auris the same as a common thrush infection?
No. C. auris is a distinct, multi-drug-resistant species that behaves more like a multi-resistant organism than common Candida. It needs specific laboratory identification and specific precautions (ACSQHC, 2025).
Can staff carry Candida auris home to their families?
Transmission is mainly through contact with colonised people, surfaces, and equipment in care settings. Hand hygiene and precautions reduce this risk. Every day household contact is not the main route.
Do visitors need to wear personal protective equipment?
Visitors should perform hand hygiene on entering and leaving the room. PPE is not required unless they provide direct care. A visitor who will see other residents should visit the resident with C. auris last and wear an apron in the room.
Ready to strengthen infection prevention in your facility?
The IPS HUB gives aged care facilities across Australia and New Zealand continuously updated IPC policies, audit tools, training, and direct support from experienced IPC professionals. Book a 15-minute call with our IPC Consultant: https://infectioncontrol.care/contact
References and Further Reading
Clinical Excellence Commission (NSW). Information for clinicians — Candida auris, Version 1.0. Sydney: CEC; July 2025.
Queensland Health. Candida auris (C. auris) infection prevention and control. Brisbane: Queensland Health; Version 3.2 2024.
Australasian Society for Infectious Diseases. Diagnosis, management and prevention of Candida auris in hospitals (position paper).
World Health Organization. WHO fungal priority pathogens list. Geneva: WHO; 2022.
Australian Commission on Safety and Quality in Health Care. Aged Care Infection Prevention and Control Guide, Version 1.1. Sydney: ACSQHC; January 2025.

About the Author
Lyndon Forrest is the Managing Director of Bug Control — Infection Prevention Services, with over 30 years’ experience supporting aged care facilities across Australia and New Zealand with infection prevention, antimicrobial stewardship, and accreditation readiness.
Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors.
IPC Scenario Risk Assessment Tool
Apply these risk management principles with our interactive IPC Scenario Risk Assessment Tool — designed specifically for aged care facilities to identify, assess, and control infection risks.
Ready to Strengthen Your Facility’s Infection Prevention?
The IPS Hub provides aged care facilities across Australia and New Zealand with continuously updated IPC policies, AMS tools, outbreak management resources, and direct support from experienced IPC professionals.

